Myopia
Conditions
Interventions
Continuous treatment group:None
Discontinuation group:None
Switching group:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Received RLRL treatment at our hospital during the study period; 2.Have verifiable baseline data and at least 1 post-treatment follow-up visit; 3.Have baseline and follow-up data of at least either AL or SER; 4.For those included in the imaging analysis, have interpretable baseline and follow-up OCT data; 5.For those included in the withdrawal strategy analysis, have a clear time node of treatment discontinuation or switching;
Exclusion criteria
Exclusion criteria: 1.Poor image quality, uncorrectable segmentation errors, or missing key variables; 2.Unverifiable RLRL exposure or treatment discontinuation/switching information; 3.Complicated with binocular vision dysfunction such as amblyopia and strabismus; 4.Suffering from other severe ocular or systemic diseases; 5.Obvious logical errors in core clinical medical records;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annualized axial length (AL) change rate (mm/year);Annualized spherical equivalent refraction (SER) change rate (D/year); | — |
Secondary
| Measure | Time frame |
|---|---|
| The changes of choroidal thickness (central, 3 mm nasal, 3 mm temporal) and luminal area (LA) in each region; | — |
Countries
China
Contacts
Public ContactLu Yi
Shanghai General Hospital
Outcome results
None listed